THG Investments is a private investment firm with a focus of delivering quality risk-adjusted returns in healthcare real estate and healthcare-oriented, niche-play operating companies. THG relies on experience, resources, and leadership to produce returns and increase value in an investment. THG's core real estate investment strategy is focused on the development and acquisition of medical office and other healthcare-related facilities. THG's current portfolio consists of approximately 400,000 SF, representing over $60,000,000 of value. THG's operating company investments have focused on healthcare facility management services as well as healthcare technology. THG's current portfolio of companies includes: Catalyst CRE, a corporate service, real estate strategy and facility management firm geared towards middle market healthcare, and Intelligent Retinal Imaging Systems (IRIS), a diabetic retinopathy screening and quality outcome-focused company. At any moment, THG is prepared to capitalize on their vision, expertise, and far-reaching network to create new or enhance existing business and investment opportunities. Since 2001, THG has worked closely with strategic partners and clients to create value and returns by implementing an honest and disciplined strategy to each unique investment opportunity.